STATERA BIOPHARMA INC's ticker is and the CUSIP is 857561104. A total of 33 filers reported holding STATERA BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30,749 | -37.2% | 378,677 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | -55.9% | 378,677 | -2.7% | 0.00% | – |
| Q2 2022 | $111,000 | -9.0% | 389,110 | 0.0% | 0.00% | – |
| Q1 2022 | $122,000 | -87.3% | 389,110 | -6.8% | 0.00% | – |
| Q4 2021 | $960,000 | -2.4% | 417,359 | -2.1% | 0.00% | – |
| Q3 2021 | $984,000 | – | 426,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bell & Brown Wealth Advisors, LLC | 18,313 | $2,000 | 0.00% |
| Virtu Financial LLC | 102,385 | $13,000 | 0.00% |
| Financial Perspectives, Inc | 8,941 | $1,161 | 0.00% |
| United Capital Management of KS, Inc. | 15,000 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 762 | $0 | 0.00% |
| NORTHERN TRUST CORP | 171,110 | $22,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 97,899 | $13,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 61,200 | $8,000 | 0.00% |
| HARBOUR INVESTMENTS, INC. | 1,381 | $0 | 0.00% |